Eschscholzia californica Cham. · herb
Evidence tier: traditional
A gentle Western nervine for sleep onset and anxiety, Native American and California settler medicine. Mild, well tolerated.
The isoquinoline alkaloids, principally californidine, eschscholtzine and protopine, are held to be responsible for the sedative and anxiolytic effects; standardised material typically contains around 0.8 percent total alkaloids expressed as californidine. Laboratory work reports modulation of GABA-A receptors and isolated californidine has shown sleep inducing and anxiolytic effects in preclinical models. Two cautions on how this is stated. First, it is preclinical: receptor binding in a dish is not a demonstrated mechanism in a person, and no adequately controlled human trial has confirmed a sedative effect for the herb alone. Second, do NOT tell people this works at the benzodiazepine binding site as if it were an established fact. California poppy is in the poppy family but it does not contain morphine like opioid alkaloids and it is not an opiate; that reassurance is fair and worth giving.
Traditional use, and thin even by that standard. The EMA HMPC registers California poppy on TRADITIONAL USE for the relief of mild symptoms of mental stress and to aid sleep, in adults only. The regulator is explicit about what that status means and what it does not: the conclusions rest on traditional use because 'although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is plausible and there is evidence that they have been used safely in this way for at least 30 years, including at least 15 years within the EU.' In other words, EMA is certifying that people have used it for a long time without obvious harm. It is not certifying that it works. There is essentially NO evidence for California poppy taken on its own. Every human study of consequence is a COMBINATION study, and the benefit cannot be assigned to the poppy. The best of them is a double blind randomised placebo controlled trial of 264 people with mild to moderate anxiety, which found benefit for a product containing California poppy PLUS hawthorn PLUS magnesium. Three actives, one result, no way to know which one moved it, or whether any of them did. The sleep evidence is weaker still: an open label, uncontrolled observational study in French primary care of 36 patients taking California poppy combined with valerian. Open label, no control group, 36 people. That is a hypothesis, not a finding. And valerian, the co ingredient, is itself graded WEAK by PlantRx's own sourced record, with a 2024 umbrella review finding no evidence of efficacy for insomnia. No NCCIH page exists. No Cochrane review exists. No systematic review of California poppy monotherapy exists, because there is essentially nothing to review. EMA also sets a hard stop: if symptoms persist beyond two weeks, stop self treating and see a doctor.
Tincture: 2 to 4 ml 30 min before bed; tea: 1 tsp dried herb steeped 10 min. Combines well with valerian.
Generally well tolerated. Avoid combining with MAOIs.
Pregnancy: avoid
Breastfeeding: avoid
Active compounds: californidine, eschscholtzine, protopine, isoquinoline alkaloids
Remedies using California Poppy · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.